Protective immunity against Chlamydia trachomatis can engage both CD4+ and CD8+ T cells and bridge the respiratory and genital mucosae

Journal of Immunology

Volumn 194, Issue 5, 2015, Pages 2319-2329

  Nogueira, Catarina V ^a   Zhang, Xuqing ^a   Giovannone, Nicholas ^a   Sennott, Erica L ^a   Starnbach, Michael N ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL HOMING; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENITAL SYSTEM; GENITAL TRACT INFECTION; IMMUNE RESPONSE; IMMUNIZATION; LUNG; LYMPHOCYTE MIGRATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT MUCOSA; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL MOTION; CELLULAR IMMUNITY; CHLAMYDIA INFECTIONS; FEMALE; HUMAN; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; MICROBIOLOGY; MUCOSA; PATHOLOGY; SECRETION (PROCESS); TRANSGENIC MOUSE; UTERUS;

ADMINISTRATION, INTRANASAL; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNIZATION; INTERFERON-GAMMA; LUNG; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUCOUS MEMBRANE; UTERUS;

EID: 84924363001     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402675     Document Type: Article

References (54)

1. + T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels. J. Virol. 80: 3732-3742.
2. Belyakov, I. M., Z. Hel, B. Kelsall, V. A. Kuznetsov, J. D. Ahlers, J. Nacsa, D. I. Watkins, T. M. Allen, A. Sette, J. Altman, et al. 2001. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat. Med. 7: 1320-1326.
3. Kunkel, E. J., and E. C. Butcher. 2002. Chemokines and the tissue-specific migration of lymphocytes. Immunity 16: 1-4.
4. von Andrian, U. H., and C. R. Mackay. 2000. T-cell function and migration. Two sides of the same coin. N. Engl. J. Med. 343: 1020-1034.
5. Campbell, J. J., G. Haraldsen, J. Pan, J. Rottman, S. Qin, P. Ponath, D. P. Andrew, R. Warnke, N. Ruffing, N. Kassam, et al. 1999. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400: 776-780.
6. + T cells. J. Exp. Med. 189: 1765-1776.
7. + skin homing T cells. J. Immunol. 169: 1189-1196.
8. + T cells activated in cutaneous or mucosal lymphoid tissues. J. Exp. Med. 195: 135-141.
9. Kunkel, E. J., J. J. Campbell, G. Haraldsen, J. Pan, J. Boisvert, A. I. Roberts, E. C. Ebert, M. A. Vierra, S. B. Goodman, M. C. Genovese, et al. 2000. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J. Exp. Med. 192: 761-768.
10. Plante, M., A. Jerse, J. Hamel, F. Couture, C. R. Rioux, B. R. Brodeur, and D. Martin. 2000. Intranasal immunization with gonococcal outer membrane preparations reduces the duration of vaginal colonization of mice by Neisseria gonorrhoeae. J. Infect. Dis. 182: 848-855.
11. Lu, C., H. Zeng, Z. Li, L. Lei, I. T. Yeh, Y. Wu, and G. Zhong. 2012. Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway. Vaccine 30: 475-485.
12. Murthy, A. K., J. P. Chambers, P. A. Meier, G. Zhong, and B. P. Arulanandam. 2007. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous γ interferon production. Infect. Immun. 75: 666-676.
13. Bomsel, M., D. Tudor, A. S. Drillet, A. Alfsen, Y. Ganor, M. G. Roger, N. Mouz, M. Amacker, A. Chalifour, L. Diomede, et al. 2011. Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Immunity 34: 269-280.
14. Lewis, D. A., A. S. Latif, and F. Ndowa. 2007. WHO global strategy for the prevention and control of sexually transmitted infections: time for action. Sex. Transm. Infect. 83: 508-509.
15. Belland, R., D. M. Ojcius, and G. I. Byrne. 2004. Chlamydia. Nat. Rev. Microbiol. 2: 530-531.
16. Beatty, W. L., G. I. Byrne, and R. P. Morrison. 1994. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease. Trends Microbiol. 2: 94-98.
17. Cohen, C. R., and R. C. Brunham. 1999. Pathogenesis of Chlamydia induced pelvic inflammatory disease. Sex. Transm. Infect. 75: 21-24.
18. Mpiga, P., and M. Ravaoarinoro. 2006. Chlamydia trachomatis persistence: an update. Microbiol. Res. 161: 9-19.
19. Chawla, R., P. Bhalla, and H. P. Sachdev. 2004. A pilot study of Chlamydia trachomatis pneumonia in infants. Indian J. Med. Microbiol. 22: 185-187.
20. + T cells. Infect. Immun. 68: 6979-6987.
21. Su, H., K. Feilzer, H. D. Caldwell, and R. P. Morrison. 1997. Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect. Immun. 65: 1993-1999.
22. Gondek, D. C., N. R. Roan, and M. N. Starnbach. 2009. T cell responses in the absence of IFN-γ exacerbate uterine infection with Chlamydia trachomatis. J. Immunol. 183: 1313-1319.
23. Johansson, M., K. Schön, M. Ward, and N. Lycke. 1997. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect. Immun. 65: 1032-1044.
24. Perry, L. L., H. Su, K. Feilzer, R. Messer, S. Hughes, W. Whitmire, and H. D. Caldwell. 1999. Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-γ-mediated inhibition. J. Immunol. 162: 3541-3548.
25. Roan, N. R., T. M. Gierahn, D. E. Higgins, and M. N. Starnbach. 2006. Monitoring the T cell response to genital tract infection. Proc. Natl. Acad. Sci. USA 103: 12069-12074.
26. Starnbach, M. N., M. J. Bevan, and M. F. Lampe. 1994. Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis. J. Immunol. 153: 5183-5189.
27. + T cell response to Chlamydia trachomatis. J. Immunol. 192: 1079-1090.
28. Morrison, R. P., K. Feilzer, and D. B. Tumas. 1995. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect. Immun. 63: 4661-4668.
29. + T cells are necessary and sufficient to confer protection against Chlamydia trachomatis infection in the murine upper genital tract. J. Immunol. 189: 2441-2449.
30. Olive, A. J., D. C. Gondek, and M. N. Starnbach. 2011. CXCR3 and CCR5 are both required for T cell-mediated protection against C. trachomatis infection in the murine genital mucosa. Mucosal Immunol. 4: 208-216.
31. Howard, L., N. S. Orenstein, and N. W. King. 1974. Purification on renografin density gradients of Chlamydia trachomatis grown in the yolk sac of eggs. Appl. Microbiol. 27: 102-106.
32. Collins, M. K., C. S. Tay, and A. Erlebacher. 2009. Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/fetal interface in mice. J. Clin. Invest. 119: 2062-2073.
33. + T cell response. J. Immunol. 171: 4742-4749.
34. Anderson, K. G., H. Sung, C. N. Skon, L. Lefrancois, A. Deisinger, V. Vezys, and D. Masopust. 2012. Cutting edge: intravascular staining redefines lung CD8 T cell responses. J. Immunol. 189: 2702-2706.
35. Bernstein-Hanley, I., J. Coers, Z. R. Balsara, G. A. Taylor, M. N. Starnbach, and W. F. Dietrich. 2006. The p47 GTPases Igtp and Irgb10 map to the Chlamydia trachomatis susceptibility locus Ctrq-3 and mediate cellular resistance in mice. Proc. Natl. Acad. Sci. USA 103: 14092-14097.
36. Williams, D. M., B. G. Grubbs, E. Pack, K. Kelly, and R. G. Rank. 1997. Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis. Infect. Immun. 65: 2876-2882.
37. Igietseme, J. U., I. M. Uriri, S. N. Kumar, G. A. Ananaba, O. O. Ojior, I. A. Momodu, D. H. Candal, and C. M. Black. 1998. Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice. Infect. Immun. 66: 4030-4035.
38. Masopust, D., V. Vezys, A. L. Marzo, and L. Lefrançois. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291: 2413-2417.
39. + T cell migration to the lung during parainfluenza virus infection. J. Immunol. 183: 4378-4384.
40. Mikhak, Z., J. P. Strassner, and A. D. Luster. 2013. Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4. J. Exp. Med. 210: 1855-1869.
41. Su, H., and H. D. Caldwell. 1995. CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect. Immun. 63: 3302-3308.
42. + T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection. Infect. Immun. 79: 2928-2935.
43. Peterson, E. M., J. Z. You, V. Motin, and L. M. de la Maza. 1999. Intranasal immunization with Chlamydia trachomatis, serovar E, protects from a subsequent vaginal challenge with the homologous serovar. Vaccine 17: 2901-2907.
44. Pabst, R., and T. Tschernig. 2010. Bronchus-associated lymphoid tissue: an entry site for antigens for successful mucosal vaccinations? Am. J. Respir. Cell Mol. Biol. 43: 137-141.
45. Kocks, J. R., A. C. Davalos-Misslitz, G. Hintzen, L. Ohl, and R. Förster. 2007. Regulatory T cells interfere with the development of bronchus-associated lymphoid tissue. J. Exp. Med. 204: 723-734.
46. Pabst, R., and I. Gehrke. 1990. Is the bronchus-associated lymphoid tissue (BALT) an integral structure of the lung in normal mammals, including humans? Am. J. Respir. Cell Mol. Biol. 3: 131-135.
47. + T lymphocytes to mucosal surfaces following intramuscular vaccination. J. Immunol. 181: 4188-4198.
48. Suvas, P. K., H. M. Dech, F. Sambira, J. Zeng, and T. M. Onami. 2007. Systemic and mucosal infection program protective memory CD8 T cells in the vaginal mucosa. J. Immunol. 179: 8122-8127.
49. Masopust, D., V. Vezys, E. J. Usherwood, L. S. Cauley, S. Olson, A. L. Marzo, R. L. Ward, D. L. Woodland, and L. Lefrançois. 2004. Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J. Immunol. 172: 4875-4882.
50. Schachter, J. 1999. Infection and Disease Epidemiology. ASM Press, Washington, DC.
51. Fadel, S. A., S. K. Bromley, B. D. Medoff, and A. D. Luster. 2008. CXCR3-deficiency protects influenza-infected CCR5-deficient mice from mortality. Eur. J. Immunol. 38: 3376-3387.
52. + T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers. Proc. Natl. Acad. Sci. USA 105: 3831-3836.
53. Bai, H., J. Cheng, X. Gao, A. G. Joyee, Y. Fan, S. Wang, L. Jiao, Z. Yao, and X. Yang. 2009. IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J. Immunol. 183: 5886-5895.
54. Scurlock, A. M., L. C. Frazer, C. W. Andrews, Jr., C. M. O'Connell, I. P. Foote, S. L. Bailey, K. Chandra-Kuntal, J. K. Kolls, and T. Darville. 2011. Interleukin-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia muridarum genital tract infection but is not required for macrophage influx or normal resolution of infection. Infect. Immun. 79: 1349-1362.